特发性炎性肌病中的肺动脉高压:血管活性治疗的初步经验
该回顾性病例系列通过右心导管检查对9例特发性炎性肌病(IIM)合并肺动脉高压(PH)患者进行分类,其中5例为WHO第3组(肺病)、1例为第2组(左心疾病)、3例为第1组(肺动脉高压,PAH)。中位随访24个月期间总死亡率为44%,33%的患者为非间质性肺病相关PH,提示PAH表型的存在。
要点
- IIM合并PH患者中约三分之一为非ILD相关PH,提示PAH表型。
- IIM患者出现呼吸困难时需警惕PAH,不应仅归因于ILD。
- 血管活性治疗在IIM相关PAH或PH-ILD中的作用尚待明确。
核心结论
- IIM合并PH患者中存在相当比例的非ILD相关PH,提示PAH表型,应提高临床医生对IIM患者呼吸困难可能源于PAH的认识。
研究设计与样本
- 回顾性病例系列,纳入9例IIM合并PH患者,通过右心导管检查评估PH类型,并评估ILD范围及血管活性治疗结局。
主要发现
- 9例患者中位PH诊断年龄62岁(IQR 48-71岁),8例女性,7例多发性肌炎、2例皮肌炎,中位病程5.7年,5例抗Jo1抗体阳性。
- PH分类:1例WHO第2组(左心疾病),5例WHO第3组(肺病),3例WHO第1组(PAH)。
- 中位随访24个月,总死亡率为44%。
- 33%的患者为非ILD相关PH,反映PAH表型的存在。
临床怎么用
- 对IIM患者出现呼吸困难时应考虑PAH可能,并进行相应评估。
- 血管活性治疗在IIM相关PAH或PH-ILD中的作用尚需进一步研究确定。
局限性
- 回顾性病例系列,样本量小(n=9),结果需更大规模研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To characterise the different types of pulmonary hypertension (PH) among idiopathic inflammatory myopathy (IIM). A retrospective case series with assessment of PH by right heart catheterisation, extent of interstitial lung disease (ILD) and outcome of vasoactive therapy.The group of patients with IIM with PH (n=9) showed a median age at PH diagnosis of 62 years (IQR 48-71 years; eight women), seven diagnosed with polymyositis and two with dermatomyositis; median disease duration of 5.7 years and five patients with a positive anti-Jo1 antibody. We found one patient to be classified in PH WHO group 2 (left heart disease), five patients in WHO group 3 (lung disease) and three patients in WHO group 1 (pulmonary arterial hypertension (PAH)). During median observed follow-up of 24 months, mortality for the total group was 44%. Surprisingly, we found a relevant group (33%) of patients with IIM who suffered from non-ILD-PH, which reflects the presence of PAH phenotype. This result should lead to more awareness among treating physicians that complaints of dyspnoea among patient with IIM could be related to PAH and not only ILD. The role of vasoactive therapy remains to be defined in patients with IIM suffering from PAH or PH-ILD.
引用
- Bhansing KJ, Vonk-Noordegraaf A, Oosterveer FP, et al. Pulmonary arterial hypertension, a novelty in idiopathic inflammatory myopathies: insights and first experiences with vasoactive therapy. RMD Open. 2017. PMID: 28879041. doi:10.1136/rmdopen-2016-000331
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。